Wireless access points are often the easiest path into a network. We test corporate Wi-Fi, guest networks, and device-to-device wireless protocols.
The short answer
Wireless penetration testing checks your office and facility Wi-Fi for ways an attacker nearby could get in. Testers look for weak encryption and authentication, rogue or look-alike access points, poor separation between guest and internal networks, and devices that connect to untrusted networks. It is different from testing a medical device's own radios, which our BLE and RF testing covers.
275+ devices supported. No cybersecurity-related rejections to date.
Wireless on a medical device is rarely just Wi-Fi. BLE pairing, proprietary RF telemetry, MICS, NFC, and cellular fallback each need their own protocol-aware testing - and reviewers expect every one of them in the report when they exist on the device.
Layers shown outermost (top) to innermost (bottom). Dashed rows are part of the surrounding system but out of scope for this view.
Every wireless penetration testing engagement ships with the artifacts FDA reviewers expect to see - traceable, complete, and aligned with current guidance.
Recalls, CISA ICS-MA advisories, and disclosed research that shape what reviewers ask about - and what this engagement is built to cover.
Unauthenticated and unencrypted proprietary RF telemetry between implants and home monitors. The single advisory most often cited when reviewers ask for evidence that proprietary RF was tested, not just Wi-Fi.
Family of BLE link-layer vulnerabilities affecting multiple medical and consumer SoCs. Drove the FDA expectation that BLE stack version, vendor advisories, and patch posture are documented in the cybersecurity package.
Wireless access points are often the easiest path into a network. We test corporate Wi-Fi, guest networks, and device-to-device wireless protocols.
